Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

Trial ID or NCT#

NCT01898403

Status

not recruiting iconNOT RECRUITING

Purpose

This clinical trial compares and contrasts lymph node mapping using indocyanine green (IC-GREEN), isosulfan blue (ISB), and TSC and Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC). Study participants with malignant melanoma will undergo all 3 evaluations to assess the extent of the spread of the melanoma.

Official Title

Testing the Efficacy of Indocyanine Green Imaging (ICG-SPY) in the Identification of Sentinel Lymph Nodes (SLN) in Patients With Malignant Melanoma

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Ability to understand and willingness to sign informed consent document - Signed written informed consent - Malignant melanoma (MM) undergoing sentinel lymph node biopsy (SNLB) - 18 years of age or older - Complete blood count (CBC) and metabolic panel within 6 months
Exclusion Criteria:
  1. - History of hepatic or renal failure - Allergy to iodine containing products - Pregnant or may be pregnant - Psychiatric or addictive disorders that in the opinion of the research team, may not be able to meet study requirements - Undergoing dialysis

Contact us to find out if this trial is right for you.

Contact

Ralph S. Greco
650-736-1355